Cycloset Interactions
There are 451 drugs known to interact with Cycloset (bromocriptine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 102 are major, 346 are moderate, and 3 are minor.
- View all 451 medications that may interact with Cycloset
- View Cycloset alcohol/food interactions (1)
- View Cycloset disease interactions (4)
Most frequently checked interactions
View interaction reports for Cycloset (bromocriptine) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Crestor (rosuvastatin)
- Dexilant (dexlansoprazole)
- Farxiga (dapagliflozin)
- fenofibrate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- glimepiride
- glipizide
- Invokana (canagliflozin)
- Januvia (sitagliptin)
- Jardiance (empagliflozin)
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- meloxicam
- metformin
- Ozempic (semaglutide)
- pioglitazone
- Synthroid (levothyroxine)
- trazodone
- Trulicity (dulaglutide)
- Victoza (liraglutide)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Cycloset alcohol/food interactions
There is 1 alcohol/food interaction with Cycloset (bromocriptine).
Cycloset disease interactions
There are 4 disease interactions with Cycloset (bromocriptine) which include:
More about Cycloset (bromocriptine)
- Cycloset consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.